| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |